Showing 2111-2120 of 8162 results for "".
Calming the Burn
https://practicaldermatology.com/topics/practice-management/calming-the-burn--fcwecwfe/18533/Physician burnout is a growing reality of today's healthcare landscape. Andrea Murina, MD talks about the problem, its increase, and its implications for dermatology. She also shares tips for finding balance.Advances in Treating NMSC
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-treating-nmsc/18742/Dr. Goldenberg discusses the benefits of timed sequential therapy using two modalities — destructive therapy followed by field therapy — for actinic keratoses. He also talks about treatment options for advanced basal cell carcinoma, squamous cell carcinoma, and merkel cell carcinoma.Heart of the Matter: Effects of Psoriasis Treatment on CV Risks
https://practicaldermatology.com/topics/psoriasis/heart-of-the-matter-effects-of-psoriasis-treatment-on-cv-risks/18747/By Jashin Wu, MD and Seemal R. Desai, MDThere's growing evidence that treatment of psoriasis reduces the risk of CV events, but it's not clear whether this potential benefit should influence treatment decisions. Patient screening and counseling remain important, Dr. Wu says.Understanding the Cosmetic Patient
https://practicaldermatology.com/topics/practice-management/understanding-the-cosmetic-patient/18785/Laurie Hurt, Marketing Director for Cosmetic Surgery and Dermatology at CareCredit, shares insights on the research and buying habits of cosmetic surgery patients gleaned from The Path to Purchase Study.Wondering with Steve and Sabrina: Mexico
https://practicaldermatology.com/topics/skin-cancer-photoprotection/wondering-with-steve-and-sabrina-mexico/18646/Traveling in the Baja Desert, Steven Dayan, MD and Sabrina Fabi, MD discover the benefits of Lomboy, a plant that can be used for sun protection. While natural isn't always better (think poison ivy), Lomboy is widely used to protect the skin because it produces a thick white paste. (C) Steven Dayan,Managing Comorbidites of Psoriasis
https://practicaldermatology.com/topics/psoriasis/managing-comorbidites-of-psoriasis/18808/Ron Prussick, MD explains why it's important for dermatologists to discuss the risks of comorbidities such as cardiovascular events, fatty liver disease, depression, and more with patients with psoriasis. While it needs to be determined if the treatments used to treat the outside effects of psoriasiLaser Advice for Early Adopters
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-advice-for-early-adopters/18809/“Fat melting is not a passing phase,” says Amy Forman Taub, MD. The technology is in its infancy, but applications will expand, she says. Dr. Taub, a laser and device expert offers suggestions on evaluating and choosing devices for a cosmetic practice. GenerationsNavigating Organizational Politics
https://practicaldermatology.com/topics/practice-management/navigating-organizational-politics/18854/Seemal Desai, MD offer tips for navigating and managing organizational politics to avoid career missteps. He also shares strategies for influencing others to help accomplish your goals in your professional and personal life.Rich Snippets - What are they, and why you should be using them?
https://practicaldermatology.com/topics/practice-management/what-are-they-and-use-you-should-be-using-them/18862/Rich snippets—those brief descriptions that appear with search engine results—can be essential to improving SEO and growing traffic for your practice. They quickly offer insight about your business. Learn how to use them optimally in this Ekwa Educational video.Cellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data o